Novavax Eyes Asia Expansion As Vaccines Portfolio Progresses
The U.S. vaccines company Novavax is making inroads into Asia and developing markets with its influenza and RSV vaccines.
The U.S. vaccines company Novavax is making inroads into Asia and developing markets with its influenza and RSV vaccines.